ARVINAS, INC. (ARVN)
Clinical trial NCT07023731 updates: 1. completion date: 2029-04-02 → 2026-11-30 2. primary completion date: 2027-11-30 → 2026-11-30
Clinical trial NCT07023731 updates: 1. completion date: 2029-04-02 → 2026-11-30 2. primary completion date: 2027-11-30 → 2026-11-30
📉 **NEGATIVE** • Medium confidence analysis (61%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (25%) **Content type:** Clinical